Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus

Clinical and Experimental Immunology

Volumn 131, Issue 3, 2003, Pages 506-516

  Hsieh, S C ^a   Yu, H S ^b   Lin, W W ^a   Sun, K H ^c   Tsai, C Y ^d   Huang, D F ^d   Tsai, Y Y ^d   Yu, Chia Li ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Antineutrophil autoantibodies; Bacterial infection; Neutropenia systemic lupus erythematosus; SSB La

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; DNA ANTIBODY; GRANULOCYTE ANTIBODY; INTERLEUKIN 8; LA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; APOPTOSIS; ARTICLE; BIOTINYLATION; CELL FUNCTION; CONTROLLED STUDY; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NEUTROPENIA; NEUTROPHIL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; BASE SEQUENCE; CHROMATOGRAPHY, AFFINITY; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; NEUTROPENIA; NEUTROPHILS; PHAGOCYTOSIS; RIBONUCLEOPROTEINS;

EID: 0344642933     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02084.x     Document Type: Article

References (56)

1. Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 1967; 126:607-24.
2. Levinsky RJ, Camerson JS, Soothill JF. Serum immune complexes and disease activity in lupus nephritis. Lancet 1977; 1:564-7.
3. Jacob L, Tron F, Bach J-F, Louvard D. A monocloncal anti-DNA antibody also binds to cell-surface proteins. Proc Natl Acad Sci USA 1984; 81:3843-5.
4. Raz E, Ben-Bassat H, Davidi T, Shlomai Z, Eilat D. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur J Immunol 1993; 23:383-90.
5. Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med 1977; 86:220-9.
6. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophils in the afferent limb of the immune response. Immunol Today 1992; 13:169-72.
7. Cassatella MA. Production of cytokines by polymorphonuclear neutrophils. In: Gabrilovich DI, ed. The neutrophils: new outlook for old cells. London: Imperial College Press, 1999:151-229.
8. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17:1-10.
9. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1979; 21:37-44.
10. Lee P, Urowitz MB, Bookman AA et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 1977; 46:1-32.
11. Zurier RB. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus. Arthritis Rheum 1976; 19:73-8.
12. Landry M. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus. Arch Dermatol 1977; 113:147-54.
13. Yu C-L, Chang K-L, Chiu C-C, Chiang BN, Han S-H, Wang S-R. Defective phagocytosis, decreased tumor necrosis factor-α production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infection. Scand J Rheumatol 1989; 18:97-105.
14. Wenger ME, Bole GG. Nitroblue tetrazolium dye reduction by peripheral leukocytes from patients with rheumatoid arthritis and systemic lupus erythematosus measured by a histochemical and spectrophotometric method. J Lab Clin Med 1973; 82:513-21.
15. Hsieh S-C, Tsai C-Y, Sun K-H et al. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12:627-33.
16. Drew SI, Terasaki PI. Autoimmune cytotoxic granulocyte antibodies in normal persons and various disease. Blood 1978; 52:941-52.
17. Lalezari P, Radel E. Neutrophil-specific antigens, immunology and clinical significance. Sem Haematol 1974; 11:281-90.
18. Jiang AF, Lalezari P. A micro-technique for detection of leukocyte agglutinins. J Immunol Meth 1975; 7:103-8.
19. Starkebaum G, Price TH, Lee PM, Arend WP. Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum 1978; 21:504-12.
20. Starkebaum G, Arend WP. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. J Clin Invest 1979; 64:902-12.
21. Hardley AG, Byron MA, Chapel HM, Bunch C, Holburn AM. Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus. Br J Haematol 1987; 65:61-5.
22. Rustagi PK, Currie MS, Logue GL. Complement-activating anti-neutrophil antibody in systemic lupus erythematosus. Am J Med 1985; 78:971-7.
23. Logue GL, Shimm DS. Autoimmune granulocytopenia. Annu Rev Med 1980; 31:191-200.
24. Sipos A, Caortos C, Sipka A, Gergely P, Sonkoly I, Szegedi G. The antigen/receptor specificity of anti-granulocyte antibodies in patients with SLE. Immunol Lett 1988; 19:329-34.
25. Gamberale R, Giordano M, Trevani AS, Andonegui G, Geffner JR. Modulation of human neutrophil apoptosis by immune complexes. J Immunol 1998; 161:3666-74.
26. Doughty R, James V, Magee JJ. An enzyme linked immunosorbent assay for leukocyte and platelet antibodies. J Immunol Meth 1981; 47:161-9.
27. Garrels JI, Gibson W. Identification and characterization of multiple forms of actin. Cell 1976; 9:793-805.
28. Young RA, Davis RW. Yeast RNA polymerase II genes: isolation with antibody probes. Science 1983; 222:778-82.
29. Young RA, Davis RW. Efficient isolation of gene using antibody probes. Proc Natl Acad Sci USA 1983; 80:1194-8.
30. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139:271-9.
31. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 1985; 135:2069-73.
32. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macophages. J Clin Invest 1989; 83:865-75.
33. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 1992; 83:639-48.
34. Whyte MK, Meagher LC, MacDermot J, Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993; 150:5124-34.
35. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993; 54:283-8.
36. Dunican AL, Leuenorth SJ, Ayala A, Simms HH. CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function in oxidative stress. Shock 2000; 13:244-50.
37. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995; 86:3181-8.
38. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 1995; 154:4719-25.
39. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58:309-14.
40. Jonsson H, Sturfelt G. A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus. Ann Rheum Dis 1990; 49:46-50.
41. Klas C, Debatin KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5:625-31.
42. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. a problem of defective apoptosis. Arthritis Rheum 1994; 37:1415-20.
43. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995; 377:348-51.
44. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449-56.
45. Muhl H, Nold M, Chang JH, Frank S, Eberhardt W, Pfeilschffter J. Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. Eur J Immunol 1999; 29:3225-35.
46. Hagimoto N, Kuwano K, Kawasaki M et al. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am J Respir Cell Mol Biol 1999; 21:436-45.
47. Lai KN, Leung JK, Lai CKW. Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-β, and nitric oxide synthase in cultured endothelial cells. Scand J Rheumatol 1997; 26:461-7.
48. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-9.
49. Willems J, Joniau M, Cinque S, Van Damme J. Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 1989; 67:140-2.
50. Peng SL, Graft J. Antinuclear antibodies. In: Ruddy S, ed. Kelley's textbook of rheumatology. Philadelphia: WB Saunders Co., 2001:167-71.
51. Baboonian C, Venables PJ, Booth J, Willianms DG, Roffe LM, Maini RN. Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol 1989; 78:454-9.
52. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992; 90:1067-76.
53. Dorner T, Hucko M, Mayet WJ, Trefzer U, Burmester GR, Hiepe F. Enhanced membrane expression of the 52kDa Ro (SS-A) and La (SS-B) antigens by human keratinocytes induced by TNF alpha. Ann Rheum Dis 1995; 54:904-9.
54. Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 1992; 2:1345-54.
55. Yanase K, Smith RM, Cizman B et al. A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies transverse the cytoplasm and enter the nucleus in a time- and temperature-dependent manner. Laboratory Invest 1994; 71:52-60.
56. Hsieh S-C, Sun K-H, Tsai C-Y et al. Monoclonal anti-double stranded DNA antibody is a leukocyte-binding protein to up-regulate interleukin-8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophils. Rheumatology (Oxford) 2001; 40:851-8.